Search results for "pan"

showing 10 items of 9912 documents

Treatment of sudden sensorineural hearing loss with transtympanic injection of steroids as single therapy: a randomized clinical study.

2011

The aim of this study was to verify the efficacy and the safety of transtympanic dexamethasone to treat sudden sensorineural hearing loss as first and single drug method. Considering ethical implication of performing a mininvasive procedure on middle ear, we matched such proposed treatment with systemic prednisone administration that represents the widest adopted protocol. Randomized prospective study was conducted. The inclusion criterion was a sudden sensorineural hearing loss of at least 30 dB across three contiguous frequencies over a period of 24 h. Group A received transtympanic steroid injections; Group B received oral administration of steroids. 25 patients were treated with transty…

AdultMalemedicine.medical_specialtyTympanic MembraneHearing Loss SensorineuralAdministration OralInjections IntralesionalRisk AssessmentSeverity of Illness IndexDexamethasoneDrug Administration ScheduleAudiometryOral administrationPrednisoneSeverity of illnessmedicineHumansProspective StudiesProspective cohort studyDexamethasoneAgedAnalysis of Variancemedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryGeneral MedicineHearing Loss SuddenMiddle AgedSurgeryCochlea Deafness Round window Sudden sensorineural hearing loss Steroid TranstympanicTreatment OutcomeOtorhinolaryngologyOtorhinolaryngologyFemaleNeurosurgeryAudiometrybusinessmedicine.drugFollow-Up Studies
researchProduct

Intratympanic Dexamethasone/Hyaluronic Acid Mix as an Adjunct to Intravenous Steroid and Vasoactive Treatment in Patients With Severe Idiopathic Sudd…

2011

To evaluate differences in effectiveness (hearing recovery rates) between idiopathic sudden sensorineural hearing loss (ISSNHL) patients treated with intravenous therapy alone and patients treated with a combination of intravenous and intratympanic therapy.Retrospective case review.Tertiary referral hospital center.Ninety-four patients with moderate ISSNHL treated with an intravenous steroid and vasoactive regimen (duration of therapy, 9 ± 2.76 d) and 76 patients with severe ISSNHL treated with a combination regimen of intravenous and intratympanic therapy (duration of therapy, 10 ± 2.71 d) were reviewed. In the latter patients' group, a series of 3 intratympanic injections of a dexamethaso…

AdultMalemedicine.medical_specialtyTympanic MembraneHearing Loss Sensorineuralmedicine.medical_treatmentIntratympanic dexamethasoneDexamethasoneInjectionsSteroidchemistry.chemical_compoundVasoactiveInternal medicineHyaluronic acidotorhinolaryngologic diseasesmedicineHumansIn patientHyaluronic AcidGlucocorticoidsRetrospective Studiesbusiness.industryHearing Loss SuddenSensory SystemsHearing recoveryTreatment OutcomeEndocrinologyOtorhinolaryngologychemistryIntravenous therapyAnesthesiaSudden sensorineural hearing lossInjections IntravenousAudiometry Pure-ToneFemaleSteroidsNeurology (clinical)businessOtology & Neurotology
researchProduct

Intratympanic Dexamethasone and Hyaluronic Acid in Patients with Low-Frequency and Ménière's-Associated Sudden Sensorineural Hearing Loss

2005

Steroids are widely used for the treatment of cochleovestibular disorders. Direct steroid application in the middle ear cavity, when combined with a round window membrane permeability-modulating substance, increases the level of the steroid reaching the target cells. We measured hearing in patients with idiopathic isolated low-frequency sensorineural hearing loss and in patients with sudden sensorineural hearing loss and a history of Ménière's disease. Contradictory reports about effectiveness of intratympanic steroid therapy on vertigo control and hearing improvement in patients with Ménière's disease exist in the literature.Eighteen patients with isolated low-frequency idiopathic sudden s…

AdultMalemedicine.medical_specialtyTympanic MembraneHearing lossHearing Loss SensorineuralAnti-Inflammatory AgentsInjections IntralesionalAudiologyDexamethasoneAdjuvants ImmunologicVertigootorhinolaryngologic diseasesmedicineHumansProspective StudiesHyaluronic AcidProspective cohort studyMeniere DiseaseDexamethasoneRound windowbiologymedicine.diagnostic_testbusiness.industryAuditory ThresholdHearing Loss SuddenMiddle Agedbiology.organism_classificationmedicine.diseaseSensory SystemsTreatment Outcomemedicine.anatomical_structureOtorhinolaryngologyMiddle earAudiometry Pure-ToneFemaleSensorineural hearing lossNeurology (clinical)medicine.symptomAudiometrybusinessmedicine.drugOtology & Neurotology
researchProduct

Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.

2007

Objectives: The intratympanic application of a low dosage of gentamicin is increasingly favored as treatment for Meniere's disease. While posttreatment observations have confirmed a long-term success of the therapy of vertigo attacks, clear differences in the posttreatment recovery interval can be observed. In addition to differences in central-vestibular compensation, the degree of peripheral vestibular damage, i.e., to the saccule, utricle, and semicircular canal ampullae, varies among patients. This study provides comprehensive pre- and posttreatment results from unilateral functional tests of the individual vestibular receptors and of the cochlea in patients with Meniere's disease. Stud…

AdultMalemedicine.medical_specialtyTympanic MembraneVestibular evoked myogenic potentialAdministration TopicalOtolithic MembraneUtricleVertigootorhinolaryngologic diseasesmedicineHumansProspective StudiesMeniere DiseaseAntibacterial agentAgedVestibular systemSemicircular canalbiologyDose-Response Relationship Drugbusiness.industryElectromyographymedicine.diseasebiology.organism_classificationSurgeryAnti-Bacterial Agentsmedicine.anatomical_structureTreatment OutcomeOtorhinolaryngologyAnesthesiaEvoked Potentials AuditoryFemalesense organsSacculeGentamicinsbusinessMeniere's diseaseFollow-Up StudiesThe Laryngoscope
researchProduct

Pharmacokinetics of atenolol in relation to renal function

1981

The plasma levels and urinary excretion of carteolol and its main metabolites 8-hydroxycarteolol and carteolol glucuronide were investigated in 6 healthy subjects and 9 patients with varying degrees of renal impairment following a single oral dose of 30 mg carteolol hydrochloride. In healthy subjects the half-life of carteolol was 7.1 h. 63% of the administered dose was recovered unchanged in urine, and in all 84% was excreted by the kidneys. The renal clearance of carteolol was 255 ml/min. In chronic renal failure (CRF) the terminal half-life was increased to a maximum of 41 h. Both the elimination rate constant and renal clearance were closely related to the creatinine clearance. In CRF t…

AdultMalemedicine.medical_specialtyUrologyAdministration OralRenal functionCarteolol HydrochloridePropanolamineschemistry.chemical_compoundPharmacokineticsElimination rate constantRenal DialysisInternal medicinemedicineHumansPharmacology (medical)CarteololAgedPharmacologyKidneyCreatinineMaintenance dosebusiness.industryGeneral MedicineMiddle AgedKineticsEndocrinologymedicine.anatomical_structureAtenololchemistryInjections IntravenousFemaleKidney DiseasesbusinessGlomerular Filtration Ratemedicine.drugEuropean Journal of Clinical Pharmacology
researchProduct

Pancreatic Fistulae after Urologic Surgery - A Single Centre Experience.

2015

<b><i>Introduction:</i></b> To evaluate incidence, symptoms and management of postoperative pancreatic fistula (POPF) after urologic surgery based on our experience. <b><i>Material and Methods:</i></b> Database was searched for clinically evident POPF after urologic surgery between 1998 and 2014. Fistulae were graded using the POPF classification. Clinical course of every POPF patient was evaluated. <b><i>Results:</i></b> During this time, 3,200 surgeries for renal, adrenal and retroperitoneal pathologies were performed. Twelve POPF occurred postoperatively in this series. Eight fistulae were POPF grade A, 3 POPF grade …

AdultMalemedicine.medical_specialtyUrologyMalignancySepsisPancreatic FistulaYoung AdultmedicineUrologic surgeryHumansAgedRetrospective StudiesAged 80 and overbusiness.industryIncidence (epidemiology)IncidenceMiddle Agedmedicine.diseaseSurgerySingle centrePancreatic fistulaUrologic Surgical ProceduresFemalePositive Surgical MarginbusinessComplicationUrologia internationalis
researchProduct

Whipple's pancreaticoduodenectomy: Surgical technique and perioperative clinical outcomes in a single center

2015

Abstract Introduction Pancreatic cancer is the fourth cause of death from cancer in Western countries. The radical surgical resection is the only curative option for this pathology. The prevalence of this disease increases with age in population. The causes of pancreatic cancer are unknown, but we consider risk factors like smoke and tobacco usage, alcohol consumption coffee, history of diabetes or chronic pancreatitis. In this study we report our experience in the treatment of resectable pancreatic cancer and periampullary neoplasms with particular attention to evaluate the evolution of surgical technique and the clinical postoperative outcomes. Methods In our Department between January 20…

AdultMalemedicine.medical_specialtyWhipple proceduremedicine.medical_treatmentPopulationPancreaticoduodenectomyPancreatic FistulaPancreatectomyPostoperative ComplicationsRisk FactorsPancreatic cancerMedicineHumanseducationAgedAged 80 and overeducation.field_of_studyGastric emptyingbusiness.industryClinical outcomePostoperative pancreatic fistulaGeneral surgeryAnastomosis SurgicalCancerGeneral MedicinePerioperativePancreatic cancerLength of StayMiddle AgedPancreaticoduodenectomymedicine.diseaseSurgeryPancreatic NeoplasmsClinical outcomes; Pancreatic cancer; Pancreaticoduodenectomy; Postoperative pancreatic fistula; Whipple procedure; SurgerySettore MED/18 - Chirurgia GeneralePancreatic fistulaPancreatitisFemaleSurgerybusinessSettore MED/36 - Diagnostica Per Immagini E Radioterapia
researchProduct

Sex differences in allelic frequencies of the 5-HT2C Cys23Ser polymorphism in psychiatric patients and healthy volunteers: findings from an associati…

2000

Polymorphisms in the serotonergic system are believed to play a role in the etiology and treatment of different psychiatric illnesses. The 5-HT2C receptor gene is X-linked, with a frequent mutation at nucleotide 68 leading to a Ser-->Cys transition at amino acid 23. Recent studies have demonstrated an impaired function of 5-HT2C receptors and an increased production of the major noradrenergic metabolite 3-methoxy-4-hydroxyphenylethyleneglycol in the cerebrospinal fluid among the subjects carrying the Ser23 allele (Lappalainen et al., 1999). Biol. Psychiatry 46:821). We genotyped patients with alcohol dependence, panic disorder without agoraphobia, generalized anxiety disorder, narcolepsy an…

AdultMalemedicine.medical_specialtyX ChromosomeGeneralized anxiety disorderGene FrequencyReference ValuesGenotypeReceptor Serotonin 5-HT2CSerineGeneticsmedicineHumansCysteineAllelePsychiatryAllele frequencyAllelesBiological PsychiatryGenetics (clinical)NarcolepsySex CharacteristicsPolymorphism Geneticbusiness.industryMental DisordersPanic disorderAlcohol dependenceMiddle Agedmedicine.diseaseAnxiety DisordersAlcoholismPsychiatry and Mental healthAmino Acid SubstitutionReceptors SerotoninPanic DisorderFemalebusinessAgoraphobiaNarcolepsyPsychiatric Genetics
researchProduct

Design and validation of a patient-reported outcome measure scale in acute pancreatitis: the PAN-PROMISE study

2021

ObjectiveThis study aimed to develop and validate a patient-reported outcome measure (PROM) in acute pancreatitis (AP) as an endpoint centred on the patient.DesignA PROM instrument (PAtieNt-rePoRted OutcoMe scale in acute pancreatItis, an international proSpEctive cohort study, PAN-PROMISE scale) was designed based on the opinion of patients, professionals and an expert panel. The scale was validated in an international multicentre prospective cohort study, describing the severity of AP and quality of life at 15 days after discharge as the main variables for validation. The COSMIN (COnsensus-based Standards for the selection of health status Measurement INstruments) methodology was applied.…

AdultMalemedicine.medical_specialtyacute pancreatitisOrdinal ScalePromCohort Studies03 medical and health sciences0302 clinical medicinePredictive Value of TestsCriterion validitymedicineHumansPatient Reported Outcome Measures030212 general & internal medicineProspective cohort studyReliability (statistics)AgedFace validityHospital Prof. Dr. Fernando Fonseca E.P.E.business.industryGastroenterologyReproducibility of ResultsPAN-PROMISE study.Middle AgedHospitalizationClinical trialClinical trialPancreatitisQuality of LifePhysical therapyFemale030211 gastroenterology & hepatologyPatient-reported outcomeSymptom AssessmentbusinessGut
researchProduct

Assessment of the quality of life in patients with varying degrees of equalization of lower limb length discrepancy treated with Ilizarov method

2021

Abstract Background Inequalities in leg length result in functional disorders, as they impair the biomechanics of the musculoskeletal system, significantly reducing the quality of life (QoL). This study used the WHOQoL-BREF questionnaire in patients with varying degrees of lower leg shortness who had undergone treatment by the Ilizarov method, compared to a healthy control group. Methods Fifty-eight patients treated with the Ilizarov method for discrepancies in lower limb length were grouped by degree of limb equalization (group 1, 37 treated individuals with limb length discrepancy < 1 cm; group 2, 21 individuals with discrepancy ≥ 1 cm but not more than 4 cm). The control group 3 conta…

AdultMalemedicine.medical_specialtylcsh:Diseases of the musculoskeletal systemIlizarov TechniqueYoung AdultQuality of life (QoL)lcsh:Orthopedic surgeryQuality of lifeSurveys and QuestionnairesIlizarov methodmedicineHumansOrthopedics and Sports MedicineIn patientLower limb length discrepancyRetrospective Studiesbusiness.industryLeg lengthLife satisfactionOdds ratioControl subjectsLeg Length Inequalitylcsh:RD701-811Limb length discrepancy (LLD)Lower ExtremityOrthopedic surgeryQuality of LifePhysical therapyFemaleSurgerylcsh:RC925-935businessResearch ArticleJournal of Orthopaedic Surgery and Research
researchProduct